EN
HI
Windlas Biotech Share Price
WINDLAS
1129.419.95 (1.80%)
NSE
BSE
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 22 Sep, 2026, Windlas Biotech stock price is ₹1129.4. During the trading session, the stock has moved between an intraday low of ₹1085.60 and an intraday high of ₹1140.00. Over the last 52 weeks, Windlas Biotech has traded between ₹697.40 and ₹1181.90.
The stock has recorded a trading volume of 1,32,476 shares,. Its Average Traded Price (ATP) is ₹1117.37, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹1129.40.
Windlas Biotech has an upper circuit limit of ₹1331.30 and a lower circuit limit of ₹887.60. The total value traded stands at ₹14.80 CR, and the delivery percentage for the day is 52.55%.
The stock is currently traded with a market lot size of 1. Windlas Biotech also offers a dividend yield of 0.57%.
Windlas Biotech Share Price Chart
Windlas Biotech Share Key Metrics
Volume
1.32 L
Market Cap
2330.66 CR
LTQ@LTP
1@1129.40
ATP
1117.37
Var Margin
19.9 %
Circuit Range
887.6-1331.3
Delivery %
52.55 %
Value
14.80 CR
ASM/GSM
No
Market Lot
1
Windlas Biotech Resistance and Support
Pivot 1116.8
Resistance
First Resistance
1129.25
Second Resistance
1149.05
Third Resistance
1161.5
Support
First Support
1097
Second Support
1084.55
Third Support
1064.75
Windlas Biotech Shareholding Pattern
View More- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
63.31%
Mutual Fund
5.76%
Insurance
0%
Foreign Institutional Investors
2.04%
Domestic Institutional Investors
4.08%
Retail
24.8%
Others
0.01%
Total Promoters
MAR '26
61.9%
JUN '26
63.31%
Windlas Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-05-21 | Audited Results & Final Dividend |
| 2026-04-17 | Buy Back of Shares |
| 2026-02-05 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-16 | 2026-07-16 | View More |
| Buyback Period | ||
|---|---|---|
| 30 Apr - 07 May 26 12.30 pm | View More |
Windlas Biotech Management
| Name | Position |
|---|---|
| Ananta Narayan Panda | Company Secretary & Compliance Officer |
| Ashok Kumar Windlass | Whole Time Director |
Windlas Biotech Similar Stocks
Sakar Healthcare Ltd.
1158.45
-21.35 (1.81%)
Dr Agarwals Eye Hospital Ltd.
5280.50
-91.00 (1.69%)
Shukra Pharmaceuticals Ltd.
55.33
-0.60 (1.07%)
Indoco Remedies Ltd.
257.59
8.58 (3.45%)
Beta Drugs Ltd.
2074.60
19.40 (0.94%)
Panacea Biotec Ltd.
376.15
8.25 (2.24%)
Sai Parenteral's Ltd.
510.85
0.10 (0.02%)
Fredun Pharmaceuticals Ltd.
1348.20
44.70 (3.43%)
Venus Remedies Ltd.
1593.20
0.00 (0.00%)
Hester Biosciences Ltd.
2188.80
-6.80 (0.31%)
Windlas Biotech FAQs
The Buying Price of Windlas Biotech share is 1129.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Windlas Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Windlas Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Windlas Biotech shares is 34.38. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Windlas Biotech shares is 4.44. Useful to assess the stock's value relative to its book value.
To assess Windlas Biotech’s valuation compare Sector P/E, P/B which are 42.35 & 3.61 with sector averages, along with growth rates and financial metrics.
The Market Cap of Windlas Biotech is 2330.66 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Windlas Biotech share price is 1181.90 & 697.40. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Windlas Biotech belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in WINDLAS
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC